Beam Therapeutics, Inc. (BEAM)
27.55
-0.45
(-1.61%)
USD |
NASDAQ |
Jan 09, 16:00
27.29
-0.26
(-0.94%)
After-Hours: 20:00
Beam Therapeutics Research and Development Expense (Quarterly): 109.77M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 92.33M |
| Twist Bioscience Corp. | 17.01M |
| ANI Pharmaceuticals, Inc. | 12.30M |
| Pacific Biosciences of California, Inc. | 26.65M |
| Regeneron Pharmaceuticals, Inc. | 1.338B |